| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/08/2004 | US6747020 Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor |
| 06/08/2004 | US6747015 Low molecular weight polymannuronate |
| 06/08/2004 | US6747006 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 06/03/2004 | WO2004046732A1 Methods for screening compounds modulating cholesterol flux and uses thereof |
| 06/03/2004 | WO2004046191A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 06/03/2004 | WO2004046172A1 Perindopril |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046145A1 Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases |
| 06/03/2004 | WO2004046138A1 Carboxamides |
| 06/03/2004 | WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | WO2004045638A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045598A1 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 06/03/2004 | WO2004045596A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | WO2004045591A2 Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004045518A2 Open chain prolyl urea-related modulators of androgen receptor function |
| 06/03/2004 | WO2004035037A3 Derivatives of n-phenylanthranilic acid and 2-benzimidazolon as potassium channel and/or cortical neuron activity modulators |
| 06/03/2004 | WO2004012759A3 Use of erythropoietin |
| 06/03/2004 | WO2004009594A3 Xanthine derivatives having adenosine a1-receptor antagonist properties |
| 06/03/2004 | WO2004005929A3 Methods and formulations for diagnosing, monitoring, staging and treating heart failure |
| 06/03/2004 | WO2004004603A9 Methods and devices for treating aneurysms |
| 06/03/2004 | WO2004002419A3 Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
| 06/03/2004 | WO2003103611A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 06/03/2004 | WO2003099194A3 Pharmaceutical combination of pde5 inhibitors with ace inhibitors |
| 06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003045369A3 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003004039A3 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106896 System and method for forming a non-ablative cardiac conduction block |
| 06/03/2004 | US20040106803 e.g., 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole; having a tyrosine kinase inhibitory action |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106797 8-ester function; metabolized by non-oxidative enzymes; primary metabolites are inactive; not subject to drug-drug interactions; water solubility and favorable metabolic profile |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106687 Carotenoids as anti-hypertension agents |
| 06/03/2004 | US20040106677 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 06/03/2004 | US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106637 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106632 5-(4-{2-'(6-methoxy-pyrimidin-4-yl)methyl-amino)-ethoxy}-benzyl)-thiazolidin-2,4-dione sodium salt |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106617 Chemical stability of levosimendan solutions can be significantly improved if the pH of the solution is lowered from neutral to lower than 5, preferably to 4.5 or lower, most preferably to 3-4.2 |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106596 Pyridoquinoxaline antivirals |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106583 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 06/03/2004 | US20040106577 decreases cerebral edema degree and other symptoms of the nerve behavior caused by cerebral ischemia and re-infusion. |
| 06/03/2004 | US20040106563 For use against vascular diesases or graft rejection. |
| 06/03/2004 | US20040106562 Drugs containing reduced of vitamin b2 |
| 06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/03/2004 | US20040106171 Peptides with anti-hypertensive properties |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105893 256 Daltons compound, non proteinesious in nature,with an Ultraviolet spectra in methanol as a solvent produces a sharp peak at 225.4 nm |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105861 Use of factor XIIIa inhibitors to treat atherosclerosis |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105843 prevention of cellular damage in disease resulting from H/I-related blood flow resistance due to occlusion of blood vessels |
| 06/03/2004 | DE10254336A1 Carbonsäureamide Carboxamides |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506724A1 Antibodies, polypeptides and uses thereof |
| 06/03/2004 | CA2506587A1 A process to prepare a pharmaceutically acceptable salt of perindopril |
| 06/03/2004 | CA2506083A1 Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonane compounds and method of treatments relating to arrhythminc events |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | CA2505915A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | CA2505752A1 Imidazo[1,5a]pyridine derivatives and methods for treating aldosterone mediated diseases |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424330A1 Activator for peroxisome proliferator-responsive receptor delta |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424101A2 Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
| 06/02/2004 | EP1423707A1 Methods of screening molecules that are used to prevent cardiovascular diseases |
| 06/02/2004 | EP1423697A2 Secreted proteins |